Memorial Şişli Hospital
Memorial Şişli Hospital
Turquie, Istanbul
Betul Tavil
29 années d'expérience
accréditations :
La clinique est certifiée :
Le coût d’un traitement complexe du sarcome d’Ewing en Turquie varie généralement de $30,000 à $55,000. Le tarif dépend de l’établissement, de l’expérience des équipes d’oncologie et de chirurgie, du nombre de cycles de chimiothérapie et de la nécessité éventuelle d’imagerie avancée ou de reconstruction prothétique. En France, le coût moyen est de $100,000 (selon l’INCa). Cela signifie que le traitement en Turquie coûte environ 57% de moins qu’en France.
Les forfaits turcs incluent habituellement les consultations initiales, les avis secondaires, l’analyse anatomopathologique, toute l’imagerie (IRM, TEP-TDM), l’hospitalisation complète pour la chimiothérapie et la chirurgie, la prothèse si nécessaire, les soins post-opératoires, les visites de suivi et une assistance 24h/24. Les services d’interprétariat et l’aide administrative sont également standards. En France, de nombreux frais – comme l’imagerie, les prothèses ou la traduction – peuvent être facturés séparément. Toujours vérifier précisément ce que chaque clinique prend en charge.
Pourquoi les patients choisissent-ils la Turquie pour le traitement complexe du sarcome d'Ewing ?
Accédez à des solutions avancées pour le traitement complexe du sarcome d'Ewing dans des cliniques de confiance .
| Turquie | Espagne | Allemagne | |
| Traitement complexe du sarcome d'Ewing | de $30,000 | de $35,000 | de $95,000 |
Le Dr Bülent Karagöz est un oncologue médical turc très expérimenté, spécialiste des sarcomes et des lymphomes, et chirurgien spécialiste du cancer du sein, avec plus de 20 ans d'expérience. Il est spécialisé dans la biologie des tumeurs, l'immunologie des tumeurs, l'immunothérapie du cancer et les thérapies ciblées. Il a rédigé plus de 40 publications dans le domaine de la recherche sur le cancer et est membre de l'Association turque d'oncologie médicale.
Spécialisé dans les cas de cancer complexes, y compris le sarcome d'Ewing, avec une formation au Hacettepe University Cancer Institute et au MD Anderson Cancer Center.
Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.
Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.
Le Dr. Assoc. Abdullah Sakin dirige le Département d'Oncologie Médicale à l'Hôpital Medipol Bahçelievler, spécialisé dans les cas de cancer complexes.
Standard Ewing sarcoma treatment in Turkey follows a multimodal protocol including induction chemotherapy, local control through surgery or radiation, and consolidation chemotherapy. Turkish centers like Anadolu Medical Center and Memorial Şişli Hospital align strictly with Euro-Ewing and Childrens Oncology Group (COG) international guidelines.
Bookimed Expert Insight: While private centers like Anadolu Medical Center collaborate with Johns Hopkins for US-standard protocols, major public university hospitals like Hacettepe offer full SGK-insured coverage for patients under 18. This creates a dual-pathway system where international patients can access the same high-tier protocols for $30,000 to $55,000, significantly lower than the $225,000 US average.
Patient Consensus: Patients emphasize discussing fertility preservation like sperm or ovarian tissue banking early, as these services are readily available in both public and private Turkish sectors. Successful outcomes often depend on the involvement of multidisciplinary tumor boards and professional translation services during complex chemotherapy cycles.
Advanced radiation technologies for Ewing's sarcoma are widely available in Turkey at JCI-accredited centers in Istanbul and Ankara. Specialized facilities provide precision tools like TrueBeam STx, CyberKnife, and MR-LINAC. These systems target tumors while protecting healthy tissue, which is vital for pediatric and spinal cases.
Bookimed Expert Insight: Quality indicators for sarcoma care in Turkey go beyond machinery. Anadolu Medical Center holds ESMO accreditation and OECI certification, making it a top-tier destination for complex oncology. Their collaboration with Johns Hopkins ensures patients receive international-level treatment plans from board-certified specialists like Professor Bulent Karagoz.
Patient Consensus: Patients value the multidisciplinary approach where radiation oncologists work alongside orthopedic surgeons. Many emphasize that the availability of pediatric-specific protocols provides peace of mind during intensive treatment cycles.
Success rates for Ewing's sarcoma in Turkey are high, with 5-year survival rates for localized cases reaching 60% to 80%. Advanced Turkish oncology centers utilize multimodal therapy, combining VAC/IE chemotherapy protocols with precision surgery and radiotherapy to achieve 3-year overall survival rates up to 91.7% for patients with negative surgical margins.
Bookimed Expert Insight: Quality of care in Istanbul centers often mirrors top U.S. institutions due to formal affiliations. Anadolu Medical Center follows strict Johns Hopkins Medicine protocols, while Hisar Hospital Intercontinental features specialists from the University of Texas MD Anderson Cancer Center. This academic crossover ensures patients receive NCCN-aligned treatment at 81% lower costs than in the United States.
Patient Consensus: Patients emphasize that early genomic profiling is vital for success. Many survivors highlight the importance of choosing high-volume centers that offer integrated mental health support to manage long-term recurrence anxiety.
Ewing's sarcoma can recur after treatment, with approximately 25% of localized and 80% of metastatic cases relapsing. Recurrence typically occurs within 2 years, often in the lungs or original tumor site. Long-term surveillance using CT or PET scans is mandatory for early detection.
Bookimed Expert Insight: Turkey’s leading oncology centers, like Anadolu Medical Center, utilize Johns Hopkins Medicine affiliations to apply identical U.S. treatment protocols at lower costs. While complex treatment in Turkey ranges from $30,000 to $55,000, patients receive care from ESMO-certified experts like Prof. Seref Komurcu. This high-level expertise is critical because the timing of the first relapse is the strongest predictor of long-term success.
Patient Consensus: Many families emphasize the reality of `scanxiety` before regular follow-up appointments. Patients stress that missing a scheduled MRI or PET scan is not an option, as early detection of a new lump or unexplained pain significantly changes the available treatment paths.
Multidisciplinary Tumor Boards in Turkish clinics centralize expert decision-making to create precise, evidence-based treatment strategies for complex cancers. By combining surgery, medical oncology, and radiation oncology, these boards ensure accurate staging and limb-sparing surgical approaches while following international medical guidelines from Joint Commission International and ESMO.
Bookimed Expert Insight: Anadolu Medical Center holds a strategic affiliation with Johns Hopkins Medicine, meaning their tumor boards often follow U.S. clinical protocols. This collaboration provides patients with access to Western-standard care and tumor biology expertise at competitive Turkish price points.
Patient Consensus: Patients describe these boards as game-changers that often shift treatment from aggressive amputation toward limb-sparing surgery. Many advise requesting the meeting summary to confirm all specialists have reviewed the biopsy results before starting treatment.
Istanbul and Ankara represent the primary medical hubs for complex Ewing's sarcoma in Turkey, hosting JCI-accredited centers with multidisciplinary sarcoma boards. These hubs utilize advanced U.S. protocols through affiliations like Johns Hopkins Medicine and offer specialized pediatric bone marrow transplant units for high-risk cases.
Bookimed Expert Insight: While Istanbul attracts the most international cases, the real differentiator for Ewing's sarcoma is the presence of a dedicated pediatric bone marrow transplant unit. Systems like Emsey Hospital or Medipol Mega operate some of the largest units in the country with up to 45 beds. This capacity often translates to shorter waiting times for the intensive consolidation phase of treatment compared to smaller regional centers.
Patient Consensus: Families emphasize selecting centers that offer Euro Ewing trial regimens and rapid chemotherapy cycles. Many suggest arranging a video consultation first to verify if limb-salvage surgery is viable before traveling.